News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Features Let’s Talk About Sex: How Best to Broach Post-MI Conversations Caitlin E. Cox June 14, 2024
News Features A Sham-Controlled Trial of AF Ablation Is Feasible, but Is It Needed? Todd Neale January 25, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Features Bloodlines: How Far Should Cardiologists Go in Treating Family? Todd Neale March 10, 2022
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance Shelley Wood April 29, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Features Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option? Shelley Wood April 30, 2019
News Features To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death Caitlin E. Cox May 02, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018